Kidney Neoplasms: all 973 studies
Page 5 of 10. Open to participants first (214), then studies with results posted, then the rest; newest registration first within each.
- KidneyCare Cohort Study (KCC-S)CompletedNCT06898632
- Randomized Clinical Trial Aimed at Comparing Unclamped Robotic Partial Nephrectomy With or Without RenorrhaphyActive, not recruitingNCT06846112Not applicable
- Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCTTerminatedNCT06818305Phase 2
- Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab DeviceCompletedNCT06789224Not applicable
- Development of AI Model for Renal Tumor Diagnosis Using CT and Lab TestsCompletedNCT06761742
- A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Colorectal, Ovarian, and Renal CancersTerminatedNCT06760702Phase 2
- Prehabilitation Prior to Surgery for Kidney TumorsActive, not recruitingNCT06745609Not applicable
- Safety and Preliminary Efficacy of Meldonium in Patients with Metastatic Renal Cell Carcinoma and Treatment-associated FatigueCompletedNCT06648902Phase 1/2
- Enhanced Assistance During Radiotherapy for Unmet Essential NeedsCompletedNCT06582849Not applicable
- A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.TerminatedNCT06546553Phase 1
- Rib Removal and Pain in Partial NephrectomyCompletedNCT06543095
- Impact of Perioperative Anesthetic Management on Renal Cancer Progression.WithdrawnNCT06536244
- Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer PatientsCompletedNCT06531629
- Optimization of Management for Sporadic Bilateral Renal Cell CarcinomaCompletedNCT06369519
- PSMA Therapy and Immunotherapy in Kidney CancerWithdrawnNCT06361810Phase 1/2
- Prospective Evaluation of AI R&D Tool for Patient Stratification: a Trial for Renal Immuno-oncology Model Experimental Evaluation 2TerminatedNCT06264479
- AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)Active, not recruitingNCT06245915Phase 1/2
- Primary Care-Based Follow-up of Cancer Survivors of the Prostate and KidneyCompletedNCT06214000
- CALM: Managing Distress in Malignant Brain CancerCompletedNCT06180460Not applicable
- Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer SurvivorsCompletedNCT06171945Not applicable
- Retrospective Analysis of the Correlation Between Imaging Features and Pathology, Prognosis in Renal TumorsCompletedNCT06167863
- MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular MarkersActive, not recruitingNCT06126159Not applicable
- Advanced Diffusion Imaging in Renal Cancer PatientsActive, not recruitingNCT06116253Not applicable
- HPI Effect in Robotic Urological Surgery on AKICompletedNCT06051162Not applicable
- Clinical Study of 18F -FAPI-RGD in Renal TumorCompletedNCT05976607
- Preferences of Patients Treated With Oral Cancer Drugs and Informal Caregivers for Pharmaceutical Consultation in HospitalCompletedNCT05970471
- Linking In With Advice and Supports for Men Impacted by Metastatic CancerActive, not recruitingNCT05946993Not applicable
- An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF)No longer availableNCT05941637
- Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)TerminatedNCT05935748Phase 2
- A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of InterestCompletedNCT05899361Not applicable
- Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial NephrectomyActive, not recruitingNCT05887245
- A Phase 1 Clinical Study of NXP900 in Subjects With Advanced CancersActive, not recruitingNCT05873686Phase 1
- Integrated Actionable Aging Assessment for Cancer Patients PilotActive, not recruitingNCT05871008Not applicable
- A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsCompletedNCT05864144Phase 1/2
- A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced MalignanciesTerminatedNCT05861947Phase 1
- A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).CompletedNCT05858749
- NSAID Use After Robotic Partial NephrectomyActive, not recruitingNCT05842044Phase 2
- Assessment of Complications in Patients Who Underwent LPN According to the CCICompletedNCT05823545
- The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)Active, not recruitingNCT05820087Not applicable
- Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial)Active, not recruitingNCT05817604
- Nephrogreen. Appearances of Exvivo Renal Tumours Under Near-infraredCompletedNCT05735977Not applicable
- Valveless Trocar Versus Standard Trocar in Robot-assisted Complex Partial NephrectomyStatus unknownNCT05732857Not applicable
- Three-dimensional Virtual Imaging to Improve the Accuracy of Standard CT-based Nephrometric Scores: a Prospective Multicentric Observational StudyCompletedNCT05729763
- A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)CompletedNCT05708950Phase 1/2
- Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsActive, not recruitingNCT05704985Phase 1
- A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid TumorsActive, not recruitingNCT05672459Phase 1/2
- Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination ImmunotherapyCompletedNCT05579847
- A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced CancersActive, not recruitingNCT05544929Phase 1
- The Association of Marital Status With Kidney Cancer Surgery MorbidityCompletedNCT05526599
- Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)Active, not recruitingNCT05520099
- Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)WithdrawnNCT05487859Phase 2
- GI Organ Tracking Via Balloon ApplicatorsWithdrawnNCT05471401Not applicable
- A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024)Active, not recruitingNCT05468697Phase 1/2
- Percutaneous Cryoablation of Central Kidney Tumours With Temporary Renal Artery OcclusionCompletedNCT05461027
- A Clinical Study of 6MW3211 in Patients With Renal CancerStatus unknownNCT05440045Phase 2
- Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer ProgressionStatus unknownNCT05426317Not applicable
- Partial Nephrectomy in Low PressureCompletedNCT05404685Not applicable
- Gag-layer in the Urothelium of the Human Upper Urinary TractCompletedNCT05400291
- Medico-economic Evaluation Comparing the Impact of the New Fixed-dose Nivolumab Regimen With the Old mg/kg Regimen in the Management of Patients With Metastatic CancerCompletedNCT05380336
- Complication in Laparoscopic Renal and Adrenal Surgery (CLARAS)Status unknownNCT05322265
- Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney CancerActive, not recruitingNCT05239533Phase 2
- Video Education With Result Dependent dIsclosureCompletedNCT05225428Not applicable
- CLARA: Somatic and Germline Mechanisms That Impact Renal Cancer ImmunotherapyActive, not recruitingNCT05215470Phase 2
- Study of Minimally-invasive Ablative Renal Therapies (SMART) RegistrySuspendedNCT05210933
- CARINAE for Stress Relief in Perioperative CareCompletedNCT05184725Not applicable
- Clinical-pathological Characterization and Outcomes of Renal Cell Carcinoma in Latin AmericanCompletedNCT05184504
- Tempus Priority Study: A Pan-tumor Observational StudyActive, not recruitingNCT05179824
- Complications Associated With Partial Nephrectomy for Renal CancerCompletedNCT05168761
- Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic MalignancyStatus unknownNCT05154474
- Patient Reported Outcomes by Patients With Metastatic Renal Cell CarcinomaStatus unknownNCT05135832Not applicable
- A Study of NDI 1150-101 in Patients With Solid TumorsActive, not recruitingNCT05128487Phase 1/2
- A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell CarcinomaTerminatedNCT05119335Phase 1/2
- Virtual 3D Modelling for Improved Surgical Planning of Robotic-assisted Partial NephrectomyStatus unknownNCT05109182Not applicable
- Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer CellsStatus unknownNCT05108077Phase 1/2
- Cost-effectivness of Robot-assisted Surgery Compared to Open Surgery for Partial Nephrectomy in Context of Renal TumorCompletedNCT05089006
- Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly PatientsStatus unknownNCT05068180Phase 4
- Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)Active, not recruitingNCT05056077Not applicable
- A Study of Belzutifan (MK-6482) as Monotherapy and in Combination With Lenvatinib (E7080/MK-7902) With or Without Pembrolizumab (MK-3475) in China Participants With Advanced Renal Cell Carcinoma (MK-6482-010)Active, not recruitingNCT05030506Phase 1
- Ask Questions (ASQ):Implementation of a Communication InterventionCompletedNCT05025748Not applicable
- Mixed Reality Technology in Laparoscopic Partial NephrectomyCompletedNCT05015179Not applicable
- Prospective Validation of the Prognostic Value of Long Non-coding MFI2-AS1 RNA in Localized Clear Cell Kidney CancersStatus unknownNCT04946266
- LPN in Patients With High-complex Renal TumorsCompletedNCT04933604
- Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney CancerActive, not recruitingNCT04922307Not applicable
- A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various CancerWithdrawnNCT04889495
- Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney CancerCompletedNCT04883827
- DS Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy)CompletedNCT04869462
- DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)CompletedNCT04825834
- 18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain MetastasesCompletedNCT04752267Early Phase 1
- Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell CarcinomaStatus unknownNCT04698213Phase 2
- German National Registry for NSSTerminatedNCT04681690
- Neoadjuvant PD-1 Monoclonal Antibody Plus Cisplatin-based Chemotherapy in Locally Advanced Upper Tract Urothelial CarcinomaStatus unknownNCT04672317Phase 2
- Contrast Ultrasound Dispersion Imaging (CUDI) as a Diagnostic Modality in the Diagnosis of Renal Cell CarcinomaStatus unknownNCT04669613Not applicable
- Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell CarcinomaStatus unknownNCT04644432Phase 2
- Diagnostic Value of Sonazoid Contrast-enhanced Ultrasound in Renal TumorsStatus unknownNCT04626115
- Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer PatientsCompletedNCT04604158Not applicable
- Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell CancerWithdrawnNCT04603365Phase 2
- Hyper-Personalized Medicine Using Patient Derived Xenografts (PDXovo) for Metastatic Solid TumorsStatus unknownNCT04602702
- MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK TrialWithdrawnNCT04580836Phase 2
- A Phase 1 Study of GNR-051 in Subjects With Advanced MalignanciesCompletedNCT04544748Phase 1
- A Comparative Study Between Open and Robotic Partial Nephrectomy in Treatment of High Complex Renal Tumors.CompletedNCT04537247Not applicable